Stem cells are undifferentiated cells of most multi-cellular living organisms able to renew themselves and to repair or create new cells of whatever body’s tissue. They are classified into the two principal categories: adult/“somatic” and embryonic stem cells. According to stem cells’ “potency” the following types are distinguished: totipotent, oligopotent, pluripotent, unipotent, multipotent and stem cells. Oncology, bone/cartilage and cardiology therapeutic industries are the main users of stem cells.
In 2010, the world stem cell market exceeded USD 21 billion. It exhibited considerable upturn over the recent several years and is expected to override USD 63 billion in 2015. North America, Europe and the Asia-Pacific are the top regional markets. The market growth is spurred by the rising demand given the enhancing consumers’ interest in the stem cell products. Geron, Advanced Cell Technology and Neuralstem are the dominant players of the worldwide market.
This MarketPublishers’ catalogue contains research reports providing an extensive guide to the stem cell market. The studies include valuable information on the market size and structure; characterize the market dynamics; identify major factors influencing the market. The researches examine the competitive landscape; describe performance of the leading companies, besides offering their detailed profiles. In addition, data on price trends, consumption changes, the most recent industry activities, product launches as well as future market forecasts are available in the research reports.
Publications found:
96
Sort by:
